Countries China
Ablaze Pharmaceuticals to Develop GPC3 Targeted Therapy for Liver Cancer in China
The proprietary GPC3 targeting peptide is being licensed from RayzeBio pursuant to an existing license agreement. Upon in-license of product candidates by ...
March 31, 2023 | News
ImmVira's MVR-C5252 for Malignant Glioma Approved for Clinical Trial in China
In July 2022, the Company entered into a cooperative agreement with China Resource Biopharma ("CRBio") to jointly develop MVR-C5252 in the Greate...
March 30, 2023 | Regulatory
Scivita Medical enters into Strategic Agreement with Boston Scientific in China
Under Scivita Medical's comprehensive product lineup of reusable endoscopes, single-use videoscopes and related systems and equipment, this cooperation fur...
March 30, 2023 | News
Kintor Pharma Completes Enrollment for KX-826 Phase III Trial for Male Androgenetic Alopecia in China
The Phase III clinical trial is a randomized, double-blind, placebo-controlled, multi-regional study designed to evaluate the efficacy and safety of 5mg (0...
March 29, 2023 | News
Antengene Doses First Patient with ATG-022 for Advanced Solid Tumors in Australia
Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antig...
March 29, 2023 | News
Boan Biotech Announces 2022 Financial Results
Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights Record high in revenue: In...
March 28, 2023 | News
Berry Genomics and Ajlan & Bros Holdings Form Joint Venture to Support 'Vision 2030'
The joint venture will focus on genetic testing in the field of reproductive health and carry out in-depth collaboration on a series of projects that lever...
March 28, 2023 | News
Everest Medicines receives full payment from Gilead for Trodelvy transaction, boosting cash reserves
"With the full upfront payment and other reimbursement from Gilead, we now have an even stronger balance sheet to advance development of products in our co...
March 28, 2023 | News
WuXi Biologics Reports Remarkable 2022 Annual Results
2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...
March 23, 2023 | News
Jacobio Collaborates to Evaluate JAB-BX102 with KEYTRUDA® for Cancer Patients.
Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co., Inc., Rahway, NJ, USA to evaluate the combinatio...
March 22, 2023 | News
Agilis Robotics has begun its first trial in mainland China, marking a significant advancement in the country's robotic endoscopic surgery.
The Agilis Robotics system is designed to make endoscopic and endoluminal surgery easier, faster, and more precise. The ultra-thin instruments ar...
March 20, 2023 | News
Connect Biopharma's CBP-201 demonstrates swift relief of Atopic Dermatitis symptoms in pivotal study in China
Stage 1 of ongoing 52-week China pivotal AD trial met primary and secondary endpoints No efficacy plateau at Week 16 In the study “CBP-201, a n...
March 20, 2023 | News
Keymed Biosciences Advancing Clinical Progress and Global Collaboration
Development of Innovative and Differentiated Pipelines Core Product CM310 (IL-4Rα antibody): Initiated Phase III registrational cl...
March 18, 2023 | News
China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval
On December 22, 2022, Likang submitted an IND application for LK101 Injection to NMPA, and received application shortly after. LK101 Injection, the fi...
March 17, 2023 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
